Nephrology, Children's National Hospital, 111 Michigan Avenue NW, Washington, D.C., 20010, USA.
Cardiology, Children's National Hospital, Washington, D.C., 20010, USA.
Pediatr Nephrol. 2023 Jun;38(6):1887-1896. doi: 10.1007/s00467-022-05771-3. Epub 2022 Nov 10.
Children with kidney failure have increased risk for cardiovascular morbidities before and after transplantation. Ejection fraction is often preserved, masking cardiac dysfunction until severe. Data on longitudinal changes in diastolic function and cardiac geometry are limited.
A prospective study was conducted to investigate longitudinal changes in diastolic function and structure pre- and post-kidney transplant compared with healthy peers. Transplant recipients (n = 41) had echocardiograms pre-transplant, 1, 18, 30, and 42 months post-transplant. The controls (n = 26) underwent one echocardiogram. Diastolic function and cardiac geometry were assessed by E/e' lateral, E/A, interventricular septal end diastole diameter, left ventricular internal end diastole diameter, left ventricular posterior wall end diastole diameter, and left atrial dimension.
E/e' of patients remained worse than controls until 30 months post-transplant, and E/A was impaired at all time points compared to the controls. Left ventricular geometry was abnormal in 46% pre-transplant and remained altered in 44.7%, 32.3%, 30.7%, and 27.2% at 1, 18, 30, and 42 months post-transplant. Determinants of diastolic dysfunction included hemodialysis, uncontrolled hypertension, steroid exposure, and metabolic syndrome; abnormal geometry was associated with glomerular diagnosis, dialysis duration, obesity, steroids, and metabolic syndrome. Abnormal diastolic function and structure were associated with left ventricular hypertrophy.
Diastolic dysfunction and geometry partially improve after transplant but remain abnormal in a subset of patients compared to healthy peers. Traditional indicators of systolic function are preserved. Modifiable risk factors include dialysis modality and duration, uncontrolled hypertension, corticosteroids, obesity, and metabolic syndrome. Attention to diastolic changes provides opportunity for early intervention. A higher resolution version of the Graphical abstract is available as Supplementary information.
儿童肾衰竭患者在移植前后发生心血管疾病的风险增加。射血分数通常保持不变,直到严重程度才会出现心脏功能障碍。关于舒张功能和心脏结构的纵向变化的数据有限。
进行了一项前瞻性研究,以调查与健康同龄人相比,肾移植前后舒张功能和结构的纵向变化。移植受者(n=41)在移植前、移植后 1、18、30 和 42 个月进行了超声心动图检查。对照组(n=26)进行了一次超声心动图检查。通过 E/e' 侧壁、E/A、室间隔舒张末期直径、左室内径舒张末期直径、左室后壁舒张末期直径和左房直径评估舒张功能和心脏结构。
移植后 30 个月内,患者的 E/e' 仍差于对照组,E/A 各时间点均较对照组受损。移植前左心室几何结构异常占 46%,移植后 1、18、30 和 42 个月仍分别有 44.7%、32.3%、30.7%和 27.2%的患者存在异常。舒张功能障碍的决定因素包括血液透析、未控制的高血压、类固醇暴露和代谢综合征;异常的几何结构与肾小球疾病、透析持续时间、肥胖、类固醇和代谢综合征有关。异常的舒张功能和结构与左心室肥厚有关。
舒张功能障碍和几何结构在移植后部分改善,但与健康同龄人相比,仍有一部分患者异常。传统的收缩功能指标保持不变。可改变的危险因素包括透析方式和时间、未控制的高血压、皮质类固醇、肥胖和代谢综合征。对舒张变化的关注为早期干预提供了机会。图形摘要的更高分辨率版本可在补充信息中查看。